Ascrinvacumab has been used in clinical studies examining the treatment and fundamental science of various neoplasms, including advanced solid tumors, hepatocellular carcinoma, and malignant pleural mesothelioma. The DrugMonitor™ Anti-Ascrinvacumab Antibody (VS-1224-YC115) is an anti-drug antibody (ADA) against Ascrinvacumab. This drug-based antibody is raised in mice immunized with the Ascrinvacumab. The anti-Ascrinvacumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Ascrinvacumab in samples.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Afuco™ Anti-ACVRL1 ADCC Recombinant Antibody, ADCC EnhancedThis product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to ACVRL1. It is a human monoclonal antibody that can be potentially used in the treatment of Mesothelioma, pleural malignant, Hepatocellular carcinoma (HCC).
There are currently no Customer reviews or questions for VS-1224-YC115. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.